Annual ROE
-42.10%
-0.43%-1.03%
31 December 2023
Summary:
Intellia Therapeutics annual return on equity is currently -42.10%, with the most recent change of -0.43% (-1.03%) on 31 December 2023. During the last 3 years, it has fallen by -7.92% (-23.17%). NTLA annual ROE is now -172.00% below its all-time high of 58.47%, reached on 31 December 2015.NTLA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-51.64%
-2.71%-5.54%
30 September 2024
Summary:
Intellia Therapeutics quarterly return on equity is currently -51.64%, with the most recent change of -2.71% (-5.54%) on 30 September 2024. Over the past year, it has dropped by -8.82% (-20.60%). NTLA quarterly ROE is now -169.37% below its all-time high of 74.44%, reached on 31 March 2016.NTLA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NTLA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -20.6% |
| 3 y3 years | -23.2% | -43.3% |
| 5 y5 years | -15.8% | -41.6% |
NTLA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.2% | at low | -43.3% | at low |
| 5 y | 5 years | -25.0% | at low | -43.3% | at low |
| alltime | all time | -172.0% | at low | -169.4% | at low |
Intellia Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -51.64%(+5.5%) |
| June 2024 | - | -48.93%(+9.2%) |
| Mar 2024 | - | -44.79%(+4.6%) |
| Dec 2023 | -42.10%(+1.0%) | -42.82%(-0.1%) |
| Sept 2023 | - | -42.87%(-1.0%) |
| June 2023 | - | -43.29%(+2.3%) |
| Mar 2023 | - | -42.32%(-11.9%) |
| Dec 2022 | -41.67%(+21.9%) | -48.04%(+4.5%) |
| Sept 2022 | - | -45.98%(+2.8%) |
| June 2022 | - | -44.73%(+0.5%) |
| Mar 2022 | - | -44.49%(+23.4%) |
| Dec 2021 | -34.18%(+1.5%) | -36.05%(-5.3%) |
| Sept 2021 | - | -38.08%(-7.4%) |
| June 2021 | - | -41.14%(+10.8%) |
| Mar 2021 | - | -37.12%(-4.6%) |
| Dec 2020 | -33.69% | -38.89%(-4.7%) |
| Sept 2020 | - | -40.80%(-0.1%) |
| June 2020 | - | -40.83%(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -40.99%(+12.4%) |
| Dec 2019 | -36.34%(+23.2%) | -36.47%(+9.7%) |
| Sept 2019 | - | -33.25%(+1.3%) |
| June 2019 | - | -32.82%(+5.5%) |
| Mar 2019 | - | -31.12%(+3.3%) |
| Dec 2018 | -29.50%(+11.5%) | -30.12%(-12.2%) |
| Sept 2018 | - | -34.32%(+2.6%) |
| June 2018 | - | -33.46%(+1.7%) |
| Mar 2018 | - | -32.89%(+4.6%) |
| Dec 2017 | -26.46%(-21.1%) | -31.45%(+15.2%) |
| Sept 2017 | - | -27.31%(+22.6%) |
| June 2017 | - | -22.27%(-2.3%) |
| Mar 2017 | - | -22.79%(-13.1%) |
| Dec 2016 | -33.54%(-157.4%) | -26.22%(-2.0%) |
| Sept 2016 | - | -26.76%(-28.5%) |
| June 2016 | - | -37.41%(-150.3%) |
| Mar 2016 | - | 74.44%(+27.3%) |
| Dec 2015 | 58.47% | 58.47% |
FAQ
- What is Intellia Therapeutics annual return on equity?
- What is the all time high annual ROE for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly ROE year-on-year change?
What is Intellia Therapeutics annual return on equity?
The current annual ROE of NTLA is -42.10%
What is the all time high annual ROE for Intellia Therapeutics?
Intellia Therapeutics all-time high annual return on equity is 58.47%
What is Intellia Therapeutics quarterly return on equity?
The current quarterly ROE of NTLA is -51.64%
What is the all time high quarterly ROE for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly return on equity is 74.44%
What is Intellia Therapeutics quarterly ROE year-on-year change?
Over the past year, NTLA quarterly return on equity has changed by -8.82% (-20.60%)